Udo Bonnet

3.2k total citations
130 papers, 2.2k citations indexed

About

Udo Bonnet is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Udo Bonnet has authored 130 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Psychiatry and Mental health, 38 papers in Pharmacology and 35 papers in Cellular and Molecular Neuroscience. Recurrent topics in Udo Bonnet's work include Cannabis and Cannabinoid Research (23 papers), Neuroscience and Neuropharmacology Research (21 papers) and Alcoholism and Thiamine Deficiency (17 papers). Udo Bonnet is often cited by papers focused on Cannabis and Cannabinoid Research (23 papers), Neuroscience and Neuropharmacology Research (21 papers) and Alcoholism and Thiamine Deficiency (17 papers). Udo Bonnet collaborates with scholars based in Germany, United Kingdom and United States. Udo Bonnet's co-authors include Norbert Scherbaum, Martin Wiemann, D. Bingmann, Ulrich W. Preuss, Michael Specka, Markus Gastpar, Tobias Leniger, F. Markus Leweke, Markus Banger and Heath B. McAnally and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and British Journal of Pharmacology.

In The Last Decade

Udo Bonnet

119 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Udo Bonnet Germany 27 612 606 456 452 385 130 2.2k
Adam M. Kaye United States 25 439 0.7× 320 0.5× 375 0.8× 596 1.3× 195 0.5× 140 2.9k
Ahmed Elkashef United States 28 664 1.1× 1.4k 2.4× 549 1.2× 584 1.3× 219 0.6× 58 2.4k
Finn Bengtsson Sweden 28 457 0.7× 1.2k 1.9× 927 2.0× 646 1.4× 368 1.0× 75 3.4k
Luca Steardo Italy 32 654 1.1× 495 0.8× 546 1.2× 524 1.2× 510 1.3× 106 3.1k
Dominika Dudek Poland 29 472 0.8× 421 0.7× 303 0.7× 1.2k 2.6× 166 0.4× 247 3.4k
Shih‐Ku Lin Taiwan 31 550 0.9× 728 1.2× 413 0.9× 1.3k 3.0× 142 0.4× 126 3.0k
Madia Lozupone Italy 34 621 1.0× 289 0.5× 700 1.5× 820 1.8× 271 0.7× 144 4.4k
Gerhard A. Wiesbeck Switzerland 34 423 0.7× 776 1.3× 371 0.8× 382 0.8× 271 0.7× 127 3.4k
Nathan Herrmann Canada 25 592 1.0× 440 0.7× 395 0.9× 779 1.7× 252 0.7× 62 3.2k
Sebastian Härtter Germany 33 844 1.4× 532 0.9× 471 1.0× 1.0k 2.3× 163 0.4× 81 3.8k

Countries citing papers authored by Udo Bonnet

Since Specialization
Citations

This map shows the geographic impact of Udo Bonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Bonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Bonnet more than expected).

Fields of papers citing papers by Udo Bonnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udo Bonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Bonnet. The network helps show where Udo Bonnet may publish in the future.

Co-authorship network of co-authors of Udo Bonnet

This figure shows the co-authorship network connecting the top 25 collaborators of Udo Bonnet. A scholar is included among the top collaborators of Udo Bonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udo Bonnet. Udo Bonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scherbaum, Norbert & Udo Bonnet. (2025). Drogenbezogene Probleme im psychiatrischen Konsildienst. Der Nervenarzt. 96(4). 336–341.
2.
Pum, M.E., et al.. (2025). Psychotherapy Research Domain Criteria: functional mechanisms of treatment and a basic theory of the mind. Frontiers in Psychiatry. 16. 1549976–1549976.
3.
Wager, Julia, et al.. (2024). clinicalsignificance: Clinical Significance Analyses of Intervention Studies in R. Journal of Statistical Software. 111(1). 1 indexed citations
4.
Bonnet, Udo & Georg Juckel. (2024). Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update. Fortschritte der Neurologie · Psychiatrie. 94(01/02). 14–33.
5.
6.
Scherbaum, Norbert, et al.. (2023). Exploratory Growth Mixture Modeling of Cannabis-Withdrawal Syndrome Trajectories of Adult Pure Cannabis Dependents During Detoxification: Two Subtypes?. Journal of Psychoactive Drugs. 56(4). 1–12. 2 indexed citations
7.
Scherbaum, Norbert, et al.. (2022). Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials. Frontiers in Psychiatry. 13. 867878–867878. 10 indexed citations
8.
Specka, Michael, Thomas Kuhlmann, Udo Bonnet, et al.. (2022). Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment. Frontiers in Psychiatry. 13. 868346–868346.
9.
Bonnet, Udo, et al.. (2021). Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction. Cannabis and Cannabinoid Research. 7(5). 670–676. 4 indexed citations
10.
Scherbaum, Norbert, et al.. (2020). High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 111. 110144–110144. 10 indexed citations
11.
12.
Scherbaum, Norbert, et al.. (2018). Outcome of a hepatitis B vaccination program for clients of a drug consumption facility. Journal of Clinical Virology. 106. 28–32. 6 indexed citations
13.
Bonnet, Udo, et al.. (2018). ON THE ADDICTIVE POWER OF GABAPENTINOIDS: A MINI-REVIEW. Psychiatria Danubina. 30(2). 142–149. 44 indexed citations
14.
Bonnet, Udo, et al.. (2018). Screening for physical and behavioral dependence on non-opioid analgesics in a German elderly hospital population. Addictive Behaviors. 90. 265–271. 8 indexed citations
15.
Bonnet, Udo. (2016). How much alcohol is in ketamine's antidepressant action?. Life Sciences. 168. 54–57. 6 indexed citations
16.
Richter, Christoph, Tom Bschor, Udo Bonnet, et al.. (2012). Efficacy and Safety of Levetiracetam for the Prevention of Alcohol Relapse in Recently Detoxified Alcohol-Dependent Patients. Journal of Clinical Psychopharmacology. 32(4). 558–562. 21 indexed citations
17.
Bonnet, Udo. (2011). Einschätzung des Abhängigkeitsrisikos von Propofol. Fortschritte der Neurologie · Psychiatrie. 79(8). 442–452. 13 indexed citations
18.
Bonnet, Udo, et al.. (2011). Cannabis-Hyperemesis-Syndrom. Fortschritte der Neurologie · Psychiatrie. 80(2). 98–101. 5 indexed citations
19.
Bonnet, Udo, Norbert Scherbaum, & Martin Wiemann. (2007). The endogenous alkaloid harmane: Acidifying and activity-reducing effects on hippocampal neurons in vitro. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(2). 362–367. 11 indexed citations
20.
Maschke, Matthias, Johannes Weber, A. Dimitrova, et al.. (2004). Age-related changes of the dentate nuclei in normal adults as revealed by 3D fast low angle shot (FLASH) echo sequence magnetic resonance imaging. Journal of Neurology. 251(6). 740–6. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam M. Kaye Breakdown of academic impact, for papers by Ahmed Elkashef Breakdown of academic impact, for papers by Finn Bengtsson Breakdown of academic impact, for papers by Luca Steardo Breakdown of academic impact, for papers by Dominika Dudek Breakdown of academic impact, for papers by Shih‐Ku Lin Breakdown of academic impact, for papers by Madia Lozupone Breakdown of academic impact, for papers by Gerhard A. Wiesbeck Breakdown of academic impact, for papers by Nathan Herrmann Breakdown of academic impact, for papers by Sebastian Härtter
Rankless by CCL
2026